Asentamientos prehistóricos en la Sierra de Atapuerca: poblamiento y uso del espacio prehistórico : prospección de las terrazas del río Arlanzón y estudio de sus asentamientos a través de la industria lítica
2002/01/01 by John A. Heit, W. Michael O’Fallon, W. Michael O'Fallon +6 · 27 citations
Arts and Humanities · Social Sciences · #Archaeological and Geological Studies #Archaeological and Historical Studies #Urbanism, Landscape, and Tourism Studies
paper · doi:10.1001/archinte.162.11.1245
Abstract
Factors associated with institutionalization independently account for more than 50% of all cases of venous thromboembolism in the community. Greater emphasis should be placed on prophylaxis for hospitalized medical patients. Other recognized risk factors account for about 25% of all cases of venous thromboembolism, while the remaining 25% of cases are idiopathic.
Cited by
- The association between cancer diagnosis, care, and outcomes in 1 million patients hospitalized for acute pulmonary embolism
- Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls
- Venous thromboembolism in the outpatient setting. [europepmc]
- Upper extremity deep vein thrombosis: a community-based perspective. [europepmc]
- The epidemiology of venous thromboembolism in the community. [europepmc]
- New insights into cancer-associated thrombosis. [europepmc]
- Epidemiology of cancer-related venous thromboembolism. [europepmc]
- Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. [europepmc]
- Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. [europepmc]
- Venous thromboembolism and prognosis in cancer. [europepmc]
- Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol. [europepmc]
- Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? [europepmc]
- New insights into the mechanisms of venous thrombosis. [europepmc]
- Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. [europepmc]
- Risk of venous thromboembolism in patients with rheumatoid arthritis. [europepmc]
- Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. [europepmc]
- Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis. [europepmc]
- Epidemiology of venous thromboembolism. [europepmc]
- National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged ≥65 Years in the United States (1999 to 2010). [europepmc]
- The epidemiology of venous thromboembolism. [europepmc]
- Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study. [europepmc]
- Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism. [europepmc]
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. [europepmc]
- Disturbed homocysteine metabolism is associated with cancer. [europepmc]
- American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. [europepmc]
- Beyond thrombosis: the impact of tissue factor signaling in cancer. [europepmc]
- A comprehensive review of obstructive sleep apnea. [europepmc]
Related